<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20(6)</volume><submitter>Silva TCAD</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Female aging is characterized by a decline in ovarian function until the establishment of the post-menopausal state. Other research lines seek to understand how the gut microbiota contributes to these diseases at all stages of life, including post-menopause, and its potential to be used as an ally to promote healthy aging and as a biomarker that can be associated with the pre-and post-menopausal period.&lt;h4>Methods&lt;/h4>Post-menopausal women (n = 44) aged between 45 and 60, divided into Group A n = 34 (up to 10 years postmenopause) and Group B n = 10 (more than 10 years postmenopause) had fecal samples analyzed by metabarcoding using the 16S rRNA gene, and bacterial composition and diversity were compared between the two groups.&lt;h4>Results&lt;/h4>Both groups showed high diver</pubmed_abstract><journal>PloS one</journal><pagination>e0324712</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12176181</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Microbiota and Postmenopause: The resilience of intestinal bacteria in the face of female hormonal aging.</pubmed_title><pmcid>PMC12176181</pmcid><pubmed_authors>Oliveira JAG</pubmed_authors><pubmed_authors>Moraes LAG</pubmed_authors><pubmed_authors>Rosse I</pubmed_authors><pubmed_authors>Guerra-Sa R</pubmed_authors><pubmed_authors>Silva TCAD</pubmed_authors><pubmed_authors>Goes-Neto A</pubmed_authors><pubmed_authors>Azevedo VAC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microbiota and Postmenopause: The resilience of intestinal bacteria in the face of female hormonal aging.</name><description>&lt;h4>Background&lt;/h4>Female aging is characterized by a decline in ovarian function until the establishment of the post-menopausal state. Other research lines seek to understand how the gut microbiota contributes to these diseases at all stages of life, including post-menopause, and its potential to be used as an ally to promote healthy aging and as a biomarker that can be associated with the pre-and post-menopausal period.&lt;h4>Methods&lt;/h4>Post-menopausal women (n = 44) aged between 45 and 60, divided into Group A n = 34 (up to 10 years postmenopause) and Group B n = 10 (more than 10 years postmenopause) had fecal samples analyzed by metabarcoding using the 16S rRNA gene, and bacterial composition and diversity were compared between the two groups.&lt;h4>Results&lt;/h4>Both groups showed high diver</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T07:54:55.43Z</modification><creation>2026-04-26T03:10:38.905Z</creation></dates><accession>S-EPMC12176181</accession><cross_references><pubmed>40531943</pubmed><doi>10.1371/journal.pone.0324712</doi></cross_references></HashMap>